Dr. Erich Hunziker is the founder and Chairman of the Board of discoveric bio group. He was Chairman of the Board of Directors of BB Biotech AG until 2023 and previously served as CFO of Roche from 2001 to 2010. From 1983 to 2001 he held various executive positions at Corange, Boehringer Mannheim and at Diethelm-Keller-Group (DKSH), where he ultimately served as CEO.
In 2013 he was the seed investor to support EngMab AG, which successfully developed a BCMA-bispecific antibody. EngMab was sold to Celgene in 2016.
Dr. Erich Hunziker is Chairman of Entsia International AG and since July 2019 Chairman of NovImmune/Light Chain Bioscience. He is also a co-founder and Chairman of the LamKap Bio Group and has been Chairman of discoveric marketplace ag since 2020.
He earned a Ph.D. in Industrial Engineering from the Swiss Federal Institute of Technology in Zurich.
